StemRad
PrivateLast Round
Series C
Dec 4, 2017
Total Funding Raised
$6M
Company Overview
StemRad operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Series C round in December 2017.
StemRad is a personal protective equipment company that develops and manufactures selective radiation shielding for first responders, military personnel, medical teams, and astronauts.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Defense Tech, Space Technology, Medical Imaging
Business Model
B2G
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StemRad Comparables
Compare StemRad with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rampart IC | 71% | |
| TIDI Products | 70% | |
| Salus Scientific | 62% |
For institutional investors. Book with your work email.
StemRad Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
StemRad Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Drs. Kiran & Pallavi Patel Family Office | VC Round |
| Wanaka Capital Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 58% MoM.
- Jun 1, 2025
Monthly visitors increased 72% MoM, reaching 9.8K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesAug 13, 2026
StemRad Inc. launched AstroRad radiation-shielding vest on Dec 31st '22.
- partners_withAug 13, 2026
StemRad Inc. partners with Lockheed Martin Corporation to develop AstroRad, a wearable radiation-protection vest that addresses harmful ionizing radiation in human space exploration.
For institutional investors. Book with your work email.
StemRad Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about StemRad's valuation, stock price, and market status.
Is StemRad a public or private company?
StemRad is a private company.
What is the current stock price of StemRad?
StemRad is a private company, so its shares have no public market price. Caplight tracks StemRad's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is StemRad worth (valuation)?
Valuation information for StemRad is not publicly available.
Can I buy StemRad stock?
StemRad shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was StemRad's last funding round?
StemRad's most recent funding round was Series C on December 4, 2017.
Who are the main investors in StemRad?
Key investors in StemRad include Drs. Kiran & Pallavi Patel Family Office.
Will StemRad IPO soon?
No public IPO plans have been announced for StemRad.
How can I track StemRad secondary market activity?
Caplight tracks bids, offers, and trades in StemRad's shares on secondary markets.